ZYUS Life Sciences Corporation filed its Annual on Jun 29, 2023 for the period ending Dec 31, 2022. In this report its auditor, KPMG LLP - Klynveld Peat Marwick Goerdeler, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.08 CAD | +2.86% | -9.24% | +20.00% |
May. 07 | ZYUS Life Sciences Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 23 | ZYUS Life Sciences Receives US Patent for Pain Management Drug Candidate | MT |
1st Jan change | Capi. | |
---|---|---|
+20.00% | 56.25M | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+49.84% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |
- Stock Market
- Equities
- ZYUS Stock
- News ZYUS Life Sciences Corporation
- ZYUS Life Sciences Corporation Auditor Raises 'Going Concern' Doubt